Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Plasma cell 1Other hematologic neoplasm 1Breast 1

Conditions

Breast Neoplasms 44Neoplasms 43Lung Neoplasms 28Colorectal Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 15Ovarian Neoplasms 15Pancreatic Neoplasms 13Melanoma 11Uterine Cervical Neoplasms 10Neoplastic Cells, Circulating 9Neoplasm Metastasis 9Sarcoma 8Multiple Myeloma 8Head and Neck Neoplasms 8Glioma 8Glioblastoma 8Hematologic Neoplasms 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma 6Leukemia, Myeloid, Acute 6Endometrial Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Gastrointestinal Neoplasms 5Disease 5Brain Neoplasms 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Peritoneal Neoplasms 4

Interventions

Cyclophosphamide 16fludarabine phosphate 13Peripheral Blood Stem Cell Transplantation 13Whole-Body Irradiation 10Cyclosporine 10Antilymphocyte Serum 9Melphalan 8Busulfan 8Mycophenolic Acid 7Filgrastim 6fludarabine 5Radiotherapy 5Methotrexate 5Etoposide 5Psychiatric Rehabilitation 4Methylprednisolone 4Cytarabine 4Carmustine 4Blood Specimen Collection 4thymoglobulin 3Therapeutics 3Rituximab 3Flow Cytometry 3Aprepitant 3Analgesia 3Tacrolimus 2Stem Cell Transplantation 2Proton Therapy 2Polymerase Chain Reaction 2Ondansetron 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Hodgkin Disease × Blood Specimen Collection × Clear all
NCT05595577 2026-03-20

PALS

Wake Forest University Health Sciences

Phase NA Recruiting
110 enrolled
BreastLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT06093334 2024-12-17

MinimALL

University of Erlangen-Nürnberg Medical School

Phase NA Completed
27 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04621604 2023-10-31

REVOLUMHOD

Rennes University Hospital

Phase NA Terminated
7 enrolled
Lymphoid

Hodgkin Disease

NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡